Females are underrepresented in clinical trials evaluating new stent technologies. This sub-analysis sought to assess sex-specific outcomes after bioresorbable scaffold implantation. The AIDA trial was an investigator-initiated, non-inferiority, all-comers trial,… Click to show full abstract
Females are underrepresented in clinical trials evaluating new stent technologies. This sub-analysis sought to assess sex-specific outcomes after bioresorbable scaffold implantation. The AIDA trial was an investigator-initiated, non-inferiority, all-comers trial, in which 1,845 patients were
               
Click one of the above tabs to view related content.